Street forms of "synthetic marijuana" were linked to more than 11,000 hospital emergency departments visits each year, U.S. officials say. A report by the Substance Abuse and Mental Health Services Administration said synthetic marijuana -- commonly known by such street names as "K2" or "Spice" -- are substances that are not derived from the marijuana plant but purport to have the same effect as the drug. The report pointed out that the use of synthetic cannabinoids is tied to a variety of reported symptoms, including agitation, nausea, vomiting, tachycardia -- rapid heartbeat -- elevated blood pressure, tremor, seizures, hallucinations, paranoid behavior and non-responsiveness. The report found youth ages 12-29 constituted 75 percent of all hospital emergency room visits involving synthetic cannabinoids. The average age for people involved in synthetic cannabinoid-related emergency room admissions was younger than for marijuana-related emergency room visits -- 24 years old versus 30 years old. "Healthcare professionals should be alerted to the potential dangers of synthetic cannabinoids, and they should be aware that their patients may be using these substances," Pamela S. Hyde, administrator of SAMHSA, said in a statement. "Parents, teachers, coaches and other concerned adults can make a huge impact by talking to young people, especially older adolescents and young adults, about the potential risks associated with using synthetic marijuana."
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkiller
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor